In collaboration with colleagues at Herlev Hospital and Rigshospitalet, Katarzyna will work towards precision therapy in pancreatic ductal adenocarcinoma and strategies to overcome therapy resistance using organoids.
ALT The image depicts pancreatic cancer organoids derived from ultrasound-guided fine-needle biopsies. GATA6 and MET are markers of molecular subtypes. Photo credit: Aida Marisch Delgado